Back to Boston Trust Walden Corp Boston Trust Walden Corp

HAE

31 quarters

Position history for Boston Trust Walden CorpBoston Trust Walden Corp's holdings in Haemonetics Corporation

Yes. Boston Trust Walden holds 385,355 shares of HAE (Haemonetics), worth $40.6M, as of its Q3 2026 13F filing. It reduced the position by 199,793 shares (-34.1%) from Q2 2026. Boston Trust Walden has held HAE in every 13F on record since Q1 2019, 31 quarterly filings. HAE is 0.3% of Boston Trust Walden's reported 13F portfolio.

Current Value

$40.6M

Current Shares

385,355

Total Value Change

+$30.1M

Total Shares Change

+265,763

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
385,355
-34.1%
$40.6M0.3%$105.30
0
2026-Q2
Increased
585,148
+16.6%
$43.9M0.3%$75.00
40
2026-Q1
Decreased
501,885
-13.6%
$28.3M0.2%$56.36
0
2025-Q4
Decreased
580,650
-39.3%
$46.5M0.4%$80.15
0
2025-Q3
Decreased
956,690
-12.2%
$46.6M0.3%$48.74
0
2025-Q2
Decreased
1.1M
-2.5%
$81.3M0.6%$74.61
0
2025-Q1
Increased
1.1M
+22.1%
$71.1M0.5%$63.55
50
2024-Q4
Increased
915,722
+13.1%
$71.5M0.5%$78.08
47
2024-Q3
Increased
809,608
+13.8%
$65.1M0.5%$80.38
40
2024-Q2
Decreased
711,589
-0.0%
$58.9M0.4%$82.73
0
2024-Q1
Decreased
711,865
-0.6%
$60.8M0.4%$85.35
0
2023-Q4
Decreased
716,466
-0.6%
$61.3M0.5%$85.51
0
2023-Q3
Increased
720,529
+7.7%
$64.5M0.5%$89.58
45
2023-Q2
Increased
668,860
+3.1%
$56.9M0.5%$85.14
36
2023-Q1
Increased
648,907
+3.8%
$53.7M0.5%$82.75
36
2022-Q4
Decreased
625,256
-0.6%
$49.2M0.4%$78.65
0
2022-Q3
Increased
628,825
+3.4%
$46.6M0.5%$74.03
36
2022-Q2
Decreased
607,976
-26.8%
$39.6M0.4%$65.18
0
2022-Q1
Increased
830,890
+29.5%
$52.5M0.4%$63.22
44
2021-Q4
Increased
641,433
+39.5%
$34M0.3%$53.04
46
2021-Q3
Increased
459,873
+109.5%
$32.5M0.3%$70.59
56
2021-Q2
Decreased
219,454
-4.2%
$14.6M0.1%$66.64
0
2021-Q1
Decreased
229,055
-10.2%
$25.4M0.2%$111.01
0
2020-Q4
Increased
255,172
+0.2%
$30.3M0.3%$118.75
34
2020-Q3
Increased
254,764
+27.4%
$22.2M0.3%$87.25
42
2020-Q2
Increased
200,016
+14.3%
$17.9M0.2%$89.56
39
2020-Q1
Increased
175,002
+44.0%
$17.4M0.3%$99.66
46
2019-Q4
Increased
121,485
+2.1%
$14M0.2%$114.90
34
2019-Q3
Increased
118,939
+0.8%
$15M0.2%$126.14
34
2019-Q2
Decreased
118,019
-1.3%
$14.2M0.2%$120.34
0
2019-Q1
First report
119,592
-
$10.5M0.1%$87.48
0

Other major holders of HAE: Wellington Management Group LLP, Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used